| TMCI Stock | | | USD 8.29 0.46 5.87% |
This module uses fundamental data of Treace Medical to approximate its Piotroski F score. Treace Medical F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Treace Medical Concepts. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Treace Medical financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Treace Medical Altman Z Score,
Treace Medical Correlation,
Treace Medical Valuation, as well as analyze
Treace Medical Alpha and Beta and
Treace Medical Hype Analysis.
The Treace Medical's current
Net Debt is estimated to increase to about 60.2
M, while
Short and Long Term Debt Total is projected to decrease to under 48.1
M. As of now, Treace Medical's
Capex To Depreciation is increasing as compared to previous years. The Treace Medical's current
Inventory Turnover is estimated to increase to 1.61, while
Price To Sales Ratio is projected to decrease to 3.94.
At this time, it appears that Treace Medical's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Lower Leverage| Focus | |
| Change In Outstending Shares | |
Treace Medical Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Treace Medical is to make sure Treace is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Treace Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Treace Medical's financial numbers are properly reported.
Treace Medical Concepts F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Treace Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Treace Medical in a much-optimized way.
Click cells to compare fundamentals
About Treace Medical Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Treace Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Treace Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Treace Medical's managers, analysts, and investors.
About Treace Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Treace Medical Concepts's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Treace Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Treace Medical Concepts based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Treace Medical Concepts
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock: Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Revenue Per Share | Quarterly Revenue Growth | Return On Assets | Return On Equity |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine
if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.